ResearcherShanghai Jiao Tong UniversityNo recent work listed
Yun Xi
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 3
- Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer. Co-author DOI 10.1016/j.nucmedbio.2023.108350↗
- hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2020.03.015↗
- 18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer. Co-author DOI 10.1097/mnm.0000000000000178↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Min Zhang · 3 shared papers, 2014–2023 · strength 0.39
- Paper Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resist… DOI 10.1016/j.nucmedbio.2023.108350↗
- Paper hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer. DOI 10.1016/j.canlet.2020.03.015↗
- Paper 18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer. DOI 10.1097/mnm.0000000000000178↗
- Biao Li · 3 shared papers, 2014–2023 · strength 0.39
- Paper Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resist… DOI 10.1016/j.nucmedbio.2023.108350↗
- Paper hENT1 reverses chemoresistance by regulating glycolysis in pancreatic cancer. DOI 10.1016/j.canlet.2020.03.015↗
- Paper 18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer. DOI 10.1097/mnm.0000000000000178↗
- Peng Yuan · 1 shared paper, 2020 · strength 0.13
- Ting Li · 1 shared paper, 2020 · strength 0.13
- Mo‐Fang Liu · 1 shared paper, 2020 · strength 0.13
- Rui Guo · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.